329 related articles for article (PubMed ID: 26662169)
1. Prognostic value of procalcitonin in pneumonia: A systematic review and meta-analysis.
Liu D; Su LX; Guan W; Xiao K; Xie LX
Respirology; 2016 Feb; 21(2):280-8. PubMed ID: 26662169
[TBL] [Abstract][Full Text] [Related]
2. Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study.
Bloos F; Marshall JC; Dellinger RP; Vincent JL; Gutierrez G; Rivers E; Balk RA; Laterre PF; Angus DC; Reinhart K; Brunkhorst FM
Crit Care; 2011; 15(2):R88. PubMed ID: 21385367
[TBL] [Abstract][Full Text] [Related]
3. The role of procalcitonin in adult patients with community-acquired pneumonia--a systematic review.
Berg P; Lindhardt BØ
Dan Med J; 2012 Mar; 59(3):A4357. PubMed ID: 22381083
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.
Kasamatsu Y; Yamaguchi T; Kawaguchi T; Tanaka N; Oka H; Nakamura T; Yamagami K; Yoshioka K; Imanishi M
Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525
[TBL] [Abstract][Full Text] [Related]
5. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
Ugajin M; Yamaki K; Hirasawa N; Yagi T
Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
[TBL] [Abstract][Full Text] [Related]
6. Role of combined procalcitonin and lipopolysaccharide-binding protein as prognostic markers of mortality in patients with ventilator-associated pneumonia.
Rumende CM; Mahdi D
Acta Med Indones; 2013 Apr; 45(2):89-93. PubMed ID: 23770787
[TBL] [Abstract][Full Text] [Related]
7. The value of procalcitonin level in community-acquired pneumonia in the ED.
Park JH; Wee JH; Choi SP; Oh SH
Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of procalcitonin in community-acquired pneumonia.
Horie M; Ugajin M; Suzuki M; Noguchi S; Tanaka W; Yoshihara H; Kawakami M; Kichikawa Y; Sakamoto Y
Am J Med Sci; 2012 Jan; 343(1):30-5. PubMed ID: 22207498
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis.
Liu D; Su L; Han G; Yan P; Xie L
PLoS One; 2015; 10(6):e0129450. PubMed ID: 26076027
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis.
Liu D; Xie L; Zhao H; Liu X; Cao J
BMC Infect Dis; 2016 May; 16():232. PubMed ID: 27230573
[TBL] [Abstract][Full Text] [Related]
11. Serum Procalcitonin Level and Mortality Risk in Critically ill Patients with Ventilator-Associated Pneumonia.
Li B; Zhao X; Li S
Cell Physiol Biochem; 2015; 37(5):1967-72. PubMed ID: 26584295
[TBL] [Abstract][Full Text] [Related]
12. [Role of plasma procalcitonin in the diagnosis of ventilator-associated pneumonia: systematic review and metaanalysis].
Sotillo-Díaz JC; Bermejo-López E; García-Olivares P; Peral-Gutiérrez JA; Sancho-González M; Guerrero-Sanz JE
Med Intensiva; 2014; 38(6):337-46. PubMed ID: 24035696
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of procalcitonin in community-acquired pneumonia.
Schuetz P; Suter-Widmer I; Chaudri A; Christ-Crain M; Zimmerli W; Mueller B;
Eur Respir J; 2011 Feb; 37(2):384-92. PubMed ID: 20595156
[TBL] [Abstract][Full Text] [Related]
14. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
[TBL] [Abstract][Full Text] [Related]
15. Serial procalcitonin levels for predicting prognosis in community-acquired pneumonia.
Ito A; Ishida T; Tachibana H; Ito Y; Takaiwa T
Respirology; 2016 Nov; 21(8):1459-1464. PubMed ID: 27398948
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin in early onset ventilator-associated pneumonia.
Zielińska-Borkowska U; Skirecki T; Złotorowicz M; Czarnocka B
J Hosp Infect; 2012 Jun; 81(2):92-7. PubMed ID: 22552164
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T;
Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of ventilator-associated pneumonia: a pilot, exploratory analysis of a new score based on procalcitonin and chest echography.
Zagli G; Cozzolino M; Terreni A; Biagioli T; Caldini AL; Peris A
Chest; 2014 Dec; 146(6):1578-1585. PubMed ID: 25144666
[TBL] [Abstract][Full Text] [Related]
19. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
Zhydkov A; Christ-Crain M; Thomann R; Hoess C; Henzen C; Werner Z; Mueller B; Schuetz P;
Clin Chem Lab Med; 2015 Mar; 53(4):559-66. PubMed ID: 25014522
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.
Lindstrom ST; Wong EK
Intern Med J; 2014 Apr; 44(4):390-7. PubMed ID: 24528892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
